Advanced Medical Solutions

Advanced Medical Solutions (AMS), headquartered in GB and operating within the Health and social work services (85) sector, reported a total of approximately 81.4 million kg CO2e in emissions for the 2025 financial year. This figure encompasses Scope 1 emissions amounting to about 2.8 million kg CO2e, Scope 2 emissions of approximately 5.0 million kg CO2e, and Scope 3 emissions totalling around 71.6 million kg CO2e.

For the 2024 financial year, AMS reported a total of approximately 106.6 million kg CO2e. This breakdown included Scope 1 emissions of about 2.4 million kg CO2e, Scope 2 emissions of approximately 5.2 million kg CO2e, and Scope 3 emissions totalling around 98.9 million kg CO2e.

In 2023, AMS's total emissions were approximately 51.8 million kg CO2e, with Scope 1 emissions at about 1.3 million kg CO2e, Scope 2 at approximately 1.3 million kg CO2e, and Scope 3 at around 50.5 million kg CO2e.

AMS has established significant climate commitments. The company aims for Net Zero Scope 1, 2, and 3 emissions by 2045, with a 2021 baseline. A near-term target includes a 42% absolute reduction in Scope 1 and 2 greenhouse gas emissions by 2030, also based on a 2021 baseline.

Further reinforcing these goals, the Science Based Targets initiative (SBTi) has validated AMS's commitment to reduce absolute Scope 2 greenhouse gas emissions by 42% by FY2030, from a FY2023 base year. They also commit to maintaining zero Scope 1 emissions through FY2030. In line with their Net Zero ambition, AMS has also set a target for Net-Zero Scope 3 emissions by FY2045, with a FY2024 base year, and a 30% absolute reduction in Scope 3 Category 12 (End-of-Life Treatment of Sold Products) GHG emissions per tonne of product sold by 2033. AMS also reports a projected decrease in carbon emissions to 9,891 tonnes CO2e by FY45, requiring an annual absolute reduction of 4.3% compared to their FY24 baseline.